Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-30
1997-07-22
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530385, A61K 3842, C07K 1405
Patent
active
056503881
ABSTRACT:
Polyalkylene oxide-conjugated hemoglobin solutions having a molecular weight greater than about 85,000 daltons and a degree of substitution of which substantially avoids clinically significant nephrotoxicity associated with hemoglobinuria in mammals. A method of simultaneously fractionating and purifying polyalkylene oxide-conjugated hemoglobins is al so disclosed.
REFERENCES:
patent: 4001401 (1977-01-01), Bonsen et al.
patent: 4764279 (1988-08-01), Tayot et al.
patent: 5234903 (1993-08-01), Nho et al.
patent: 5312808 (1994-05-01), Shorr et al.
patent: 5478805 (1995-12-01), Shorr et al.
Dellacherie, E. et al., "Hemoglobin-based artificial blood: new polymeric derivatives of hemoglobin with low oxygen affinity", The Int'l. Journal of Artificial Organs/vol. 14/No. 1, 1991/pp. 28-32.
Larude, P. et al., "Hemoglobin solutions coupled with ployethylene glycol 1900", The Int'l. Journal of Artificial Organs,/vol. 11/No. 5, 1988/pp. 383-402.
Menu, P., et al., "Possible Importance of Chromatographic Purification Position in a Blood Substitute Elaboration Process", Bio-Mat., Art.Cells & Immob. Biotech., 20(2-4), 443-445 (1992).
Iwasaki, Keiji, et al. "Preparation and Evaluation of Hemoglobin-Polyethylene Glycol Conjugate as an Oxygen-Carrying Resuscitation Fluid", Artificial Organs, 10(5): 411-416 (1986).
Takahashi, et al. Artificial Organs 15(6) 462-473 (1991).
Labrude, P. et al. Int'l. J. Artificial Organs vol. 11 No. 5(1988) 393-402.
Leonard, et al. Tetrahedron vol. 40, No. 9 pp. 1581-1584 (1984).
Dellacherie, E. et al. The Int'l. J. Artificial Organs vol. 14, No. 1 pp. 28-32 (1991).
Dellacherie, E. et al. Makromol. Chem. Suppl. 9 pp.43-46 (1985).
Leonard, M. et al. Biochemica et Biophysica Acta 791 pp. 219-225 (1984).
Matsushita, M. et al. vol. XXXIV Trans. Am. Soc. Artif. Intern Organs (1988) pp. 280-283.
Agishi, T. et al. Biomat., Art. Cells, Art. Org. 16(1-3) 261-270 (1988) 261-270.
Nishi, K., et al. Biomat., Art. Cells, Art Org., 16(1-3) (1988) 653-655.
Iwasaki, K., et al. Artificial Organs 10(5) pp. 411-416 (1986).
Ajisaka, K., et al. Biochemical and Biophysical Communications vol. 97, No. 3 Dec. 16, 1980 pp. 1076-1081.
Conover, C., et al "PEG-Hemoglobin effects on blood pressure and heart rate in the dog" 1993 IBC Blood Substitutes & Related Products.
Conover, C., et al "Vascular persistence of polyethylene glycol (PEG) modified hemoglobin in rats and dogs 1993 IBC Blood Substitutes & Related Products".
Nho, K., et al. "Increased Oxygen Tension in Solid Tumors Following PEG-Hemoglobin Infusion" 1993 IBC Blood Substitutes & Related Products.
PEG-Modified Hemoglobin is Exchange Transfused in Non-Shock Rat Model Abstract 3372 Fuel Metabolism I FASEBJ 6(4) PA1518 (1992).
Nho, K., et al. Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications, pp. 171-182; Harris, J. Ed. (1992).
Kide, Y., et al., "Vascular Responsiveness to Various Vasoactive Substances After Exchange Transfusion . . . " Artificial Organs 15(1) 5-14 (1991).
Matsuzawa, Y., et al. "Metabolic Rate of Pyridoxylated Hemoglobin Polyoxyethylene Conjugate in Rats and Dogs" Abstract PP1493, Pharm. Res.6(9) 1989.
Yabuki, A., et al. "Characterization of a Pyridoxylated Hemoglobin-Polyoxyethylene Conjugate as a Physiologic Oxygen Carrier" Transfusion 1990 vol. 30 No. 6 pp. 516-520.
Cerny, L., et al. "A Potential Blood Substitute From A Tetronic Polyol and a Modified Hemoglobin" Biomat., Art. Cells & Immob. Biotech., 20(1) 71-93 (1992).
Iwashita, Y., et al. "Renal Toxicity of Hemoglobin Derivatives as Blood Substitute" p. 97, et seq. citation and date unavailable.
Iwashita, Yugi, et al., "Renal Toxicity of Hemoglobin Derivatives As Blood Substitute", Miscellaneousi (5 Mar. 1981) Abstract A11.
Iwashita, Y., et al., "A New Resuscitation Fluid Stabilized Hemoglobin" Preparation and Characteristics, Biomat. Art. Cells. Art Org. 16(1-3) 271-280 (1988).
Agishi, T., et al. "Modified Hemoglobin Solution As Possible Perfusate Relevant To Organ Transplantation", Biomat. Art. Cells & Immob. Biotech. 20(2-4), 539-544 (1992).
Iwashita, Yuji, et al., "Relationship Between Chemical Properties and Biological Properties of Pyridoxalated Hemoglobin-Polyoxyethylene", Biomat., Art. Cells & Immob. Biotech., 20(2-4), 299-307 (1992).
Nho, Kwang, et al., "PEG-Bovine Hemoglobin: Safety In a Canine Dehydrated Hypovolemic-Hemorrhagic Shock Model", Biomat., Art. Cells & Immob. Biotech, 29(2-4), 511-524 (1992).
Matsumaura, Hioroaki, et al., "Pyridoxalated Hemoglobin Polyoxyethylene Conjugage (PHP) On the Encothelium-Dpendent Relaxation In Rat Mesenteric Arteriorles. Biomat., Art. Cells & Immob. Biotech.", 20(2-4), 679-681 (1992).
Matsumura, S., et al. "Large Scale Production And Characterization Of Lyophilized Pyridoxataed Hemoglobin-Polyoxyethylene (PHP), Biomat., Art. Cells & Immob. Biotech.", 20(2-4), 435-438 (1992).
Gilbert, C., et al. "Hemoglobinuria In Rats: A Sensitive Test Of Renal Filtering And Absorption Of PEG-Hemoglobin, A Red Blood Cell Substitute, Art. Cells, Blood Subs., and Immob. Biotech." 22(3), 535-541 (1994).
Bradley, R., "Production Of PEG-Modified Bovine Hemoglobin: Econimics And Feasbility", Art. Cells, Blood Subs., And Immob. Biotech., 22(3), 657-667 (1994).
Nho, K., et al., "PEG-Hemoglobin-An Efficient Oxygen-Delivery System In The Rat Exchange Transfusion And Hemovolmeic Shock Models, Art, Cells, Blood Subs., And Immob. Biotech.", 22(3), 795-803 (1994).
Linberg, R., et al., "Normal Oxygen-Tension Restored In The Ishemic Rat Liver Model By PEG-Hemoglobin, Art. Cells, Blood Subs., And Immob. Biotech.", 22(3), 805-812 (1994).
Malchesky, P.S., et al., Conjugated human hemoglobin as a physiological oxygen carrier --pyridoxalated hemoglobin polyoxyethylene conjugate (PHP), The International Journal of Artificial Organs, vol. 13, No. 7, 1990, pp. 442-450.
Lee, W.Y., et al. "Suppression of Reaginic Antibodies", Immunologial Rev. (1978), v.l. 41.
Takahashi, T., et al., "Renal Effects of Multiple Infusion of Pyridoxalated-Hemoglobin-Polyoxyethylene Conjugate (PHP) Solution in Dogs, Artificial Organs", 17(3): 153-169 (1993).
Gilbert Carl W.
Shorr Robert G. L.
Enzon Inc.
Gupta Anish
Mercanti Michael N.
Tsang Cecilia J.
LandOfFree
Fractionated polyalkylene oxide-conjugated hemoglobin solutions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fractionated polyalkylene oxide-conjugated hemoglobin solutions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fractionated polyalkylene oxide-conjugated hemoglobin solutions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1560016